3 Biggest FDA Rejections This Year (So Far)

3 Biggest FDA Rejections This Year (So Far)

In February, the FDA told a stunned Novo that additional tests would be needed to address concerns about possible cardiovascular risks with Tresiba. Shares opened 13% lower on the next trading day, with analysts speculating that the rejection would

7
Like
Save

Comments

Write a comment

*